T1	Participants 29 50	rheumatoid arthritis.
T2	Participants 227 262	patients with rheumatoid arthritis.
T3	Participants 380 546	Two hundred and one functional class I and II patients with definite or classic rheumatoid arthritis, previously untreated with disease modifying antirheumatic drugs.
T4	Participants 2146 2188	patients with active rheumatoid arthritis.
